Logo image of SNWV

SANUWAVE HEALTH INC (SNWV) Stock Fundamental Analysis

USA - NASDAQ:SNWV - US80303D3052 - Common Stock

32.26 USD
+0.05 (+0.16%)
Last: 10/10/2025, 8:58:00 PM
32.3 USD
+0.04 (+0.12%)
After Hours: 10/10/2025, 8:58:00 PM
Fundamental Rating

3

Overall SNWV gets a fundamental rating of 3 out of 10. We evaluated SNWV against 191 industry peers in the Health Care Equipment & Supplies industry. SNWV has a bad profitability rating. Also its financial health evaluation is rather negative. SNWV shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SNWV has reported negative net income.
In the past year SNWV had a positive cash flow from operations.
SNWV had negative earnings in each of the past 5 years.
In the past 5 years SNWV reported 4 times negative operating cash flow.
SNWV Yearly Net Income VS EBIT VS OCF VS FCFSNWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

The Return On Assets of SNWV (-115.07%) is worse than 80.10% of its industry peers.
Looking at the Return On Invested Capital, with a value of 43.52%, SNWV belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA -115.07%
ROE N/A
ROIC 43.52%
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNWV Yearly ROA, ROE, ROICSNWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

With an excellent Operating Margin value of 18.72%, SNWV belongs to the best of the industry, outperforming 90.58% of the companies in the same industry.
With an excellent Gross Margin value of 77.69%, SNWV belongs to the best of the industry, outperforming 90.58% of the companies in the same industry.
SNWV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.72%
PM (TTM) N/A
GM 77.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
SNWV Yearly Profit, Operating, Gross MarginsSNWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

1

2. Health

2.1 Basic Checks

SNWV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SNWV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SNWV has been increased compared to 5 years ago.
The debt/assets ratio for SNWV has been reduced compared to a year ago.
SNWV Yearly Shares OutstandingSNWV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SNWV Yearly Total Debt VS Total AssetsSNWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SNWV has an Altman-Z score of -6.42. This is a bad value and indicates that SNWV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SNWV (-6.42) is worse than 72.25% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.42
ROIC/WACC4.83
WACC9.02%
SNWV Yearly LT Debt VS Equity VS FCFSNWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

2.3 Liquidity

SNWV has a Current Ratio of 0.43. This is a bad value and indicates that SNWV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.43, SNWV is doing worse than 93.72% of the companies in the same industry.
A Quick Ratio of 0.31 indicates that SNWV may have some problems paying its short term obligations.
SNWV's Quick ratio of 0.31 is on the low side compared to the rest of the industry. SNWV is outperformed by 94.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.31
SNWV Yearly Current Assets VS Current LiabilitesSNWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

SNWV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -140.85%.
The Revenue has grown by 57.43% in the past year. This is a very strong growth!
Measured over the past years, SNWV shows a very strong growth in Revenue. The Revenue has been growing by 99.64% on average per year.
EPS 1Y (TTM)-140.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.22%
Revenue 1Y (TTM)57.43%
Revenue growth 3Y35.87%
Revenue growth 5Y99.64%
Sales Q2Q%41.92%

3.2 Future

The Earnings Per Share is expected to grow by 30.82% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 37.76% on average over the next years. This is a very strong growth
EPS Next Y100.07%
EPS Next 2Y46.11%
EPS Next 3Y30.82%
EPS Next 5YN/A
Revenue Next Year47.77%
Revenue Next 2Y40.46%
Revenue Next 3Y37.76%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SNWV Yearly Revenue VS EstimatesSNWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
SNWV Yearly EPS VS EstimatesSNWV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2025 2026 2027 0 -10 -20 -30

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

SNWV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 34.01, the valuation of SNWV can be described as expensive.
Based on the Price/Forward Earnings ratio, SNWV is valued a bit cheaper than 71.73% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.57. SNWV is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 34.01
SNWV Price Earnings VS Forward Price EarningsSNWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNWV is valued a bit cheaper than 71.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.26
SNWV Per share dataSNWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6 -8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SNWV's earnings are expected to grow with 30.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.11%
EPS Next 3Y30.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNWV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SANUWAVE HEALTH INC

NASDAQ:SNWV (10/10/2025, 8:58:00 PM)

After market: 32.3 +0.04 (+0.12%)

32.26

+0.05 (+0.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06
Inst Owners53.89%
Inst Owner Change0%
Ins Owners5.6%
Ins Owner Change0%
Market Cap276.47M
Analysts82.5
Price Target56.1 (73.9%)
Short Float %4.56%
Short Ratio8.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)101.39%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.01
P/S 7.05
P/FCF N/A
P/OCF 184.44
P/B N/A
P/tB N/A
EV/EBITDA 31.26
EPS(TTM)-8.55
EYN/A
EPS(NY)0.95
Fwd EY2.94%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.17
OCFY0.54%
SpS4.57
BVpS-1.72
TBVpS-2.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -115.07%
ROE N/A
ROCE -54.54%
ROIC 43.52%
ROICexc 120.2%
ROICexgc N/A
OM 18.72%
PM (TTM) N/A
GM 77.69%
FCFM N/A
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3.12
Cap/Depr 129.65%
Cap/Sales 4.1%
Interest Coverage 1.63
Cash Conversion 17.48%
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.31
Altman-Z -6.42
F-Score5
WACC9.02%
ROIC/WACC4.83
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.22%
EPS Next Y100.07%
EPS Next 2Y46.11%
EPS Next 3Y30.82%
EPS Next 5YN/A
Revenue 1Y (TTM)57.43%
Revenue growth 3Y35.87%
Revenue growth 5Y99.64%
Sales Q2Q%41.92%
Revenue Next Year47.77%
Revenue Next 2Y40.46%
Revenue Next 3Y37.76%
Revenue Next 5YN/A
EBIT growth 1Y406.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.56%
EBIT Next 3Y60.99%
EBIT Next 5YN/A
FCF growth 1Y99.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y111.37%
OCF growth 3YN/A
OCF growth 5YN/A